STOCK TITAN

Alpine Immune Sciences to Present at 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a clinical-stage immunotherapy company, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 2:00 p.m. ET. The presentation will highlight their innovative treatments for cancer and autoimmune diseases. A live webcast can be accessed in the investor relations section of their website, with a replay available for 90 days post-event. Alpine is recognized for its unique protein engineering technologies aimed at developing first- or best-in-class immunotherapies.

Positive
  • None.
Negative
  • None.

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021, at 2:00 p.m. ET/11:00 a.m. PT.

A live webcast of the presentation will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is creating first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

“Secreted Immunomodulatory Proteins”, “SIP”, “Transmembrane Immunomodulatory Protein,” “TIP,” “Variant Ig Domain,” “vIgD” and the Alpine logo are registered trademarks or trademarks of Alpine Immune Sciences, Inc. in various jurisdictions.

FAQ

When will Alpine Immune Sciences present at the J.P. Morgan Healthcare Conference?

Alpine Immune Sciences will present on January 14, 2021.

What time is Alpine Immune Sciences' presentation at the conference?

The presentation is scheduled for 2:00 p.m. ET.

Where can I watch the live webcast of Alpine Immune Sciences' presentation?

The live webcast can be viewed in the investor relations section of Alpine's website.

How long will the replay of Alpine Immune Sciences' presentation be available?

The replay will be available for 90 days following the webcast.

What is the focus of Alpine Immune Sciences' therapies?

Alpine focuses on developing innovative treatments for cancer and autoimmune/inflammatory diseases.

Alpine Immune Sciences, Inc.

NASDAQ:ALPN

ALPN Rankings

ALPN Latest News

ALPN Stock Data

4.46B
62.73M
4.65%
99.47%
5.93%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SEATTLE